The Prevention of Early-Onset Neonatal Group B Streptococcal Disease

Journal of Obstetrics and Gynaecology Canada

Volumn 35, Issue 10, 2013, Pages 939-948

  Money, Deborah ^a   Allen, Victoria M ^a   Yudin, Mark H ^a   Bouchard, Celine ^a   Boucher, Marc ^a   Caddy, Sheila ^a   Castillo, Eliana ^a   Murphy, Kellie E ^a   Ogilvie, Gina ^a   Paquet, Caroline ^a   Senikas, Vyta ^a   van Schalkwyk, Julie ^a  

^a NONE   (Canada)

Author keywords

Antibiotic therapy; CDC Centers for Disease Control and Prevention; GBS group B streptococcus; Group B streptococcus; Infection; IV intravenous; PCR polymerase chain reaction; PPROM preterm pre labour rupture of membranes; Prevention; PROM pre labour rupture of membranes

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN DERIVATIVE; PENICILLIN G; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CHORIOAMNIONITIS; DRUG HYPERSENSITIVITY; GROUP B STREPTOCOCCAL INFECTION; HUMAN; INFECTION PREVENTION; INTRAPARTUM CARE; LABOR INDUCTION; MASS SCREENING; NEWBORN CARE; NEWBORN INFECTION; ONSET AGE; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; STREPTOCOCCUS AGALACTIAE; SYSTEMATIC REVIEW; ANTIBIOTIC PROPHYLAXIS; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; MICROBIOLOGY; NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; STREPTOCOCCAL INFECTIONS; ANTIBIOTIC THERAPY; INFECTION; PREGNANCY COMPLICATION; PREVENTION; REVIEW; STREPTOCOCCUS INFECTION;

ANTIBIOTIC PROPHYLAXIS; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK ASSESSMENT; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

ANTIBIOTIC THERAPY; GROUP B STREPTOCOCCUS; INFECTION; PREVENTION;

EID: 84891712759     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(15)30818-5     Document Type: Article

References (73)

1. Dobson S., Money D. The prevention of early-onset neonatal group B streptococcal disease. Society of Obstetricians and Gynaecologists of Canada Clinical Practice Guideline, No. 149, September 2004. J Soc Obstet Gynaecol Can 2004, 26:826-832.
2. American Academy of Pediatrics.Pickering LK ed. Red book: 2012 report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics 2012, 29th ed.
3. Franciosi R.A., Knostman J.D., Zimmerman R.A. Group B streptococcal neonatal and infant infections. J Pediatr 1973, 82:707-718.
4. Davies H.D., Raj S., Adair C., Robinson J., McGeer A. Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation. Pediatr Infect Dis J 2001, 20:879-884.
5. Centers for Disease Control and Prevention. Perinatal group B streptococcal disease after universal screening recommendations-United States 2003-2005. Morb Mortal Wkly Rep 2007, 56:701-705.
6. Centers for Disease Control and Prevention. Trends in perinatal group B streptococcal disease-United States 2000-2006. Morb Mortal Wkly Rep 2009, 58:109-112.
7. Davies H.D., Adair C., Schuchat A., Low D.E., Suave R.S. Physicians' prevention practices and incidence of neonatal group B streptococcal disease in 2 Canadian regions. CMAJ 2001, 164:479-485.
8. Centers for Disease Control and Prevention. Prevention of group B streptococcal disease: a public health perspective. Mor Mortal Wkly Rep 1996, 45:1-24. (RR-7).
9. Schrag S.J., Zywicki S., Farley M.M., Reingold A.L., Harrison L.H., Lefkowitz L.B., et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000, 342:15-20.
10. Schuchat A., Wenger J.D. Epidemiology of group B streptococcal disease: risk factors, prevention strategies, and vaccine development. Epidemiol Rev 1994, 16:374-402.
11. Seaward P.G., Hannah M.E., Myhr T.L., Farine D., Ohlsson A., Wang E.E., et al. International multicenter term PROM study: evaluation of predictors of neonatal infection in infants born to patients with premature rupture of membranes at term. Am J Obstet Gynecol 1998, 179(3 Pt 1):635-639.
12. Money D., Dobson S., Cole L., Karacabeyli E., Blondel-Hill E., Milner R., et al. An evaluation of a rapid real time polymerase chain reaction assay for detection of group B streptococcus as part of a neonatal group B streptococcus prevention strategy. J Obstet Gynaecol Can 2008, 30:770-775.
13. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease.Mor Mortal Wkly Rep 2010, 59:1-32. (RR-10).
14. Schuchat A., Deaver-Robinson K., Plikaytis B.D., Zangwill K.M., Mohle-Boetani J.C., Wenger J.D. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. Pediatr Infect Dis J 1994, 13:623-629.
15. Royal College of Obstetricians and Gynaecologists. The prevention of early-onset neonatal group B streptococcal disease. Green-top Guideline No. 36, 2nd ed. London: RCOG; 2012.
16. Håkansson S., Källén K. Impact and risk factors for early-onset group B streptococcal morbidity: 1997-2001. BJOG 2006. analysis of a national, population-based cohort in Sweden 2006, 113:1452-1458.
17. Wood E.G., Dillon H.C. A prospective study of group B streptococcal bacteremia in pregnancy. Am J Obstet Gynecol 1981, 140:515-520.
18. Persson K., Bjerre B., Elfstrom L., Polberger S., Forsgren A. Group B streptococci at delivery: high count in urine increases risk for neonatal colonization. Scand J Infect Dis 1986, 18:525-531.
19. Yancey M.K., Schuchat A., Brown L.K., Ventura V.L., Arkenson G.R. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol 1996, 88:811-815.
20. Regan J.A., Klebanoff M.A., Nugent R.P. Vaginal Infections and Prematurity Study Group. The epidemiology of group B streptococcal colonization in pregnancy. Obstet Gynecol 1991, 77:604-610.
21. Bliss S.J., Manning S.D., Tallman P., Baker C.J., Pearlman M.D., Marrs C.F., et al. Group B streptococcus colonization in male and nonpregnant female university students: a cross-sectional prevalence study. Clin Infect Dis 2002, 34:184-190.
22. Dadvand P., Basagana X., Figueras F., Sunyer J., Nieuwenhuijsen M.J. Climate and group B streptococci colonization during pregnancy: present implications and future concerns. BJOG 2011, 118:1396-1400.
23. Schuchat A., Oxtoby M., Cochi S., Sikes R.K., Hightower A., Plikaytis B., et al. Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. J Infect Dis 1990, 162:672-677.
24. Davies H.D., Adair C., McGeer A., Ma D., Robertson S., Mucenski M., et al. Antibodies to capsular polysaccharides of group B streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate. J Infect Dis 2001, 184:285-291.
25. Schuchat A., Zywicki S.S., Dinsmoore M.J., Mercer B., Romaguera J., O'Sullivan M.J., et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter case-control study. Pediatrics 2000, 105:21-26.
26. Zaleznik D.F., Rench M.A., Hillier S.L., Krohn M.A., Platt R., Lee M.L., et al. Invasive diseases due to group B streptococcus in pregnant women and neonates from diverse population groups. Clin Infect Dis 2000, 30:276-281.
27. Adair C., Kowalsky L., Quon H., Ma D., Stoffman J., McGeer A., et al. Risk factors for early-onset group B streptococcal disease in neonates: a population-based case-control study. CMAJ 2003, 169:198-203.
28. Oddie S., Embleton N.D. Risk factors for early-onset neonatal group B streptococcal sepsis: case-control study. BMJ 2002, 325:308.
29. Ramos E., Gaudier F.L., Hearing L.R., Del Valle G.O., Jenkins S., Briones D. Group B streptococcus colonization in pregnant diabetic women. Obstet Gynecol 1997, 89:257-260.
30. Alvarez J.R., Fechner A.J., Williams S.F., Ganesh V.L., Apuzzio J.J. Asymptomatic bacteriuria in pregestational diabetic pregnancies and the role of group B streptococcus. Am J Perinatol 2012, 27:231-234.
31. Heath P.T., Balfour G.F., Tighe H., Verlander N.Q., Lamagni T.L., Efstratiou A. Group B streptococcal disease in infants: a case control study. Arch Dis Child 2009, 94:674-680.
32. Hamada S., Vearncombe M., McGreer A., Shah P.S. Neonatal group B streptococcal disease: incidence, presentation and mortality. J Matern Fetal Neonatal Med 2008, 21:53-57.
33. Rosenstein N.E., Schuchat A. Opportunities for prevention of perinatal group B streptococcal disease: a multistate surveillance analysis.The Neonatal Group B Streptococcal Disease Study Group. Obstet Gynecol 1997, 90:901-906.
34. Puopolo K.M., Madoff L.C., Eichenwald E.C. Early-onset group B streptococcal disease in the era of maternal screening. Pediatr 2005, 115:1240-1246.
35. Shah V., Ohlsson A. Canadian Task Force on Preventive Health Care. Prevention of early-onset group B Streptococcal (GBS) infection in the newborn: systematic review and recommendations. CTFPHC Technical Report 01-6. London. ON: Canadian Task Force 2001.
36. Regan J.A., Klebanoff M.A., Nugent R.P., Eschenbach D.A., Blackwelder W.C., Lou Y., et al. Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group. Am J Obstet Gynecol 1996, 174:1354-1360.
37. Feikin D.R., Thorsen P., Zywicki S., Arpi M., Westergaard J.G., Schuchat A. Association between colonization with group B streptococci during pregnancy and preterm delivery among Danish women. Am J Obstet Gynecol 2001, 184:427-433.
38. Krohn M.A., Hillier S.L., Baker C.J. Maternal peripartum complications associated with vaginal group B streptococcal colonization. J Infect Dis 1999, 179:1410-1415.
39. Rouse D.J., Goldenberg R.L., Cliver S.P., Cutter G.R., Mennemeyer S.T., Fargason C.A. Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis. Obstet Gynecol 1994, 83:483-494.
40. Allen V.M., Yudin M. Society of Obstetricians and Gynaecologists of Canada Infectious Diseases Committee. Management of group B streptococcal bacteriuria in pregnancy. SOGC Clinical Practice Guideline, No. 276, May 2012. J Obstet Gynaecol Can 2012, 34:482-486.
41. Baker C.J., Edwards M.S. Group B streptococcal infections: perinatal impact and prevention methods. Ann N Y Acad Sci 1988, 549:193-202.
42. Gardner S.E., Yow M.D., Leeds L.J., Thompson P.K., Mason E.O., Clark D.J. Failure of penicillin to eradicate group B streptococcal colonization in pregnant women: a couple study. Am J Obstet Gynecol 1979, 135:1062-1065.
43. Smaill F. Intrapartum antibiotics for group B streptococcal colonisation. Cochrane Database Syst Rev 2000, (2):000115.
44. US National Institutes of Health. Group B streptococcal vaccines 2012, Available at:, Accessed on 16 July 2012. http://clinicaltrials.gov/ct2/home.
45. Boyer K.M., Gotoff S.P. Strategies for chemoprophylaxis of GBS early onset infections. Antibiot Chemother 1985, 35:267-280.
46. Allen U.D., Navas L., King S.M. Effectiveness of intrapartum penicillin prophylaxis in preventing early-onset group B streptococcal infection: results of a meta-analysis. CMAJ 1993, 149:1659-1665.
47. Society of Obstetricians and Gynaecologists of Canada. Statement on the prevention of early-onset group B streptococcal infections in the newborn. J Soc Obstet Gynaecol Can 1997, 19:751-758.
48. Brozanski B.S., Jones J.G., Krohn M.A., Sweet R.L. Effect of a screening based prevention policy on prevalence of early-onset group B streptococcal sepsis. Obstet Gynecol 2000, 95:496-501.
49. Cheon-Lee E., Amstey M.S. Compliance with the Centers for Disease Control and Prevention antenatal culture protocol for preventing group B streptococcal neonatal sepsis. Am J Obstet Gynecol 1998, 179:77-79.
50. Gibbs R.S., McDuffie R.S., McNabb F., Fryer G.E., Miyoshi T., Merenstein G. Neonatal group B streptococcal sepsis during 2 years of a universal screening program. Obstet Gynecol 1994, 84:496-500.
51. Wendel G.D., Leveno K.J., Sanchez P.J., Jackson G.L., McIntire D.D., Siegel J.D. Prevention of neonatal group B streptococcal disease: a combined intrapartum and neonatal protocol. Am J Obstet Gynecol 2002, 186:618-626.
52. Factor S.H., Whitney C.G., Zywicki S., Schuchat A. Effects of hospital policies based on 1996 group B streptococcal disease consensus guidelines. The Active Bacterial Core Surveillance Team. Obstet Gynecol 2000, 95:377-382.
53. Van Dyke M.K., Phares C.R., Lynfield R., Thomas A.R., Arnold K.E., Craig A.S., et al. Evaluation of universal antenatal screening for group B streptococcus. New Engl J Med 2009, 360:2626-2636.
54. Ohlsson A., Shah V.S. Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst Rev 2009, (3):007467. 10.1002/14651858.CD007467.pub2.
55. Heath P.T. An update on vaccination against group B streptococcus. Expert Rev Vaccines 2011, 10:685-694.
56. Schrag S.J., Zell E.R., Lynfield R., Roome A., Arnold K.E., Craig A.S., et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002, 347:233-239.
57. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease. Mor Mortal Wkly Rep 2002, 51:1-22. (RR-11).
58. Yancey M.K., Duff P. An analysis of the cost-effectiveness of selected protocols for the prevention of neonatal group B streptococcal infection. Obstets Gynecol 2003, 83:367-371.
59. Fenton L.J., Harper M.H. Evaluation of colistin and nalidixic acid in Todd-Hewitt broth for selective isolation of group B streptococci. J Clin Microbiol 1979, 9:167-169.
60. Bland M.L., Vermillion S.T., Soper D.E. Antibiotic resistance patterns for group B streptococci in late third-trimester rectovaginal cultures. Am J Obstet Gynecol 2001, 184:1125-1126.
61. Silverman N.S., Morgan M., Nichols W.S. Antibiotic resistance patterns of group B streptococcus in antenatal genital cultures. J Reprod Med 2000, 45:979-982.
62. Price D., Shaw E., Howard M., Zazulak J., Waters H., Kaczorowski J. Self-sampling for group B streptococcus in women 35 to 37 weeks pregnant is accurate and acceptable: a randomized cross-over trial. J Obstet Gynaecol Can 2006, 28:1083-1088.
63. Valkenburg-van den burg A.W., Houtman-Roelofsen R.L., Oostvogel P.M., Dekker F.W., Dörr P.J., Sprij A.J. Timing of group B streptococcus screening in pregnancy: a systematic review. Gynecol Obstet Invest 2010, 69:174-183.
64. Bergeron M.G., Ke D., Menard C., Picard F.J., Gagnon M., Bernier M., et al. Rapid detection of group B streptococci in pregnant women at delivery. N Engl J Med 2000, 343:175-179.
65. El Helali N., Giovangrandi Y., Guyot K., Chevet K., Gutmann L., Durand-Zaleski I. Cost and effectiveness of intrapartum group B streptococcus polymerase chain reaction screening for term deliveries. Obstet Gynecol 2012, 119:822-829.
66. Amstey M.S., Gibbs R.S. Is penicillin G a better choice than ampicillin for prophylaxis of neonatal group B streptococcal infections?. Obstet Gynecol 1994, 84:1058-1059.
67. Johnson J.R., Columbo D.F., Gardner D., Cho E., Fan-Havard P., Shellhaas C.S. Optimal dosing of penicillin G in the third trimester for the prophylaxis against group B streptococcus. Am J Obstet Gynecol 2001, 185:850-853.
68. Pichichero M.E. A review of evidence supporting the American Academy of Pediatrics recommendation for prescribing cephalosporin antibiotics for penicillin-allergic patients. Pediatrics 2005, 115:1048-1057.
69. Mitchell T.F., Pearlman M.D., Chapman R.L., Bhatt-Mehta V., Faiz R.G. Maternal and transplacental pharmacokinetics of cefazolin. Obstet Gynecol 2001, 98:1075-1079.
70. Stoll B.J., Hansen N., Fanaroff A.A., Wright L.L., Carlo W.A., Ehrenkranz R.A., et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002, 347:240-247.
71. Hannah M.E., Ohlsson A., Wang E.E., Matlow A., Foster G.A., Willan A.R., et al. Maternal colonization with group B streptococcus and prelabor rupture of membranes at term: the role of induction of labor. Term PROM Study Group. Am J Obstet Gynecol 1997, 177:780-785.
72. Barrington K.J. Canadian Paediatric Society, Fetus and Newborn Committee. Position statement: management of the infant at increased risk for sepsis. Paediatr Child Health 2007, 12:893-898. Available at:, Accessed on 6 June 2013. http://www.cps.ca/en/documents/position/management-infant-sepsis.
73. Woolf S.H., Battista R.N., Angerson G.M., Logan A.G., Eel W. Canadian Task Force on Preventive Health Care. New grades for recommendations from the Canadian Task Force on Preventive Health Care. CMAJ 2003, 169:207-208.